On 31 January 2017, Diversey Europe Operations B.V. (‘the applicant’) submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).] for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘Diversey Hydrogen Peroxide Product Family’, of product-type 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-WV029790-00 in the Register for Biocidal Products. The application also indicated the case number of the related reference biocidal product family ‘Evonik's Hydrogen Peroxide Product Family’ later authorised by Commission Implementing Regulation (EU) 2023/2183 [Commission Implementing Regulation (EU) 2023/2183 of 18 October 2023 granting a Union authorisation for the biocidal product family Evonik’s Hydrogen Peroxide Product Family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2183, 19.10.2023, ELI: http://data.europa.eu/eli/reg_impl/2023/2183/oj)], recorded in that register under case number BC-UE029056-42.
Recital 1, Regulation (EU) 2024/2432
In forcesince 16 Sep 2024